{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:05:04Z","timestamp":1781877904260,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>HIV postexposure prophylaxis (PEP) following child sexual assault (CSA) is recommended in select cases. High rates of poor adherence to PEP are reported. We evaluated adherence to the recommended management of children following CSA at the tertiary pediatric facility in Western Australia and compared our approach with international guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Medical records were reviewed for all children &lt;16 years old assessed at Perth Children\u2019s Hospital between October 1, 2016 and November 30, 2020 following alleged CSA. Data, including exposure type, PEP adherence and follow-up, were collected. A review of contemporary national and international PEP guidelines was undertaken in parallel.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>There were 511 alleged CSA events over the study period; 62\/511 (12%) were appropriately risk-assessed as requiring PEP by the treating clinician. PEP was not prescribed in 8\/62 (13%) events, with a reason documented for 6\/8 (75%). Overall, less than half of children who were eligible for PEP were adherent to the 28-day regimen (23\/54, 43%). Gastrointestinal upset contributed to early cessation in 5\/54 (9%). Final 3-month blood-borne virus serology results were available in less than one in 3 children. A review of international clinical practice revealed significant heterogeneity of criteria for the provision of PEP and a paucity of pediatric-specific data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We identified several areas of our PEP management that required strengthening, with limited direction available in current international guidelines. We have adopted a broader use of fixed drug combinations and implemented a multifaceted follow-up program. It will be essential to review the impact of these changes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004370","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T19:00:36Z","timestamp":1715108436000},"page":"785-788","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia"],"prefix":"10.1097","volume":"43","author":[{"given":"Momoko","family":"Combs","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Johnson","sequence":"additional","affiliation":[{"name":"Child Protection Unit, Perth Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Abbotsford","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Perth Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha C.","family":"Bowen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands"},{"name":"Division of Paediatrics, School of Medicine, University of Western Australia, Crawley"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"McLeod","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Foley","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital"},{"name":"Department of Microbiology, PathWest Laboratory Medicine, QEII, Nedlands, Western Australia, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00038-012-0426-1","article-title":"The current prevalence of child sexual abuse worldwide: a systematic review and meta-analysis.","volume":"58","author":"Barth","year":"2013","journal-title":"Int J Public Health"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/TME.0b013e3182439e1a","article-title":"Sexual assault injuries and increased risk of HIV transmission.","volume":"34","author":"Draughon","year":"2012","journal-title":"Adv Emerg Nurs J"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1542\/peds.108.2.e38","article-title":"Human immunodeficiency virus postexposure prophylaxis for adolescents and children.","volume":"108","author":"Merchant","year":"2001","journal-title":"Pediatrics"},{"key":"R6-20250614","article-title":"Post-exposure prophylaxis (PEP) to prevent HIV infection.","author":"DeHaan","year":"2021"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archpedi.1993.02160310077023","article-title":"Pediatric acquired immunodeficiency syndrome. Barriers to recognizing the role of child sexual abuse.","volume":"147","author":"Gutman","year":"1993","journal-title":"Am J Dis Child"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/adc.75.1.85","article-title":"When is HIV an issue after child sexual abuse?.","volume":"75","author":"Mok","year":"1996","journal-title":"Arch Dis Child"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/sextrans-2014-051674","article-title":"Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa.","volume":"91","author":"Kleppa","year":"2015","journal-title":"Sex Transm Infect"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/QAD.0b013e328321302d","article-title":"Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.","volume":"23","author":"Bourry","year":"2009","journal-title":"AIDS"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"227ra235","DOI":"10.1126\/scitranslmed.3007701","article-title":"Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors.","volume":"6","author":"Dobard","year":"2014","journal-title":"Sci Transl Med"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/cid\/civ069","article-title":"Efficacy of HIV postexposure prophylaxis: systematic review and meta-analysis of nonhuman primate studies.","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/00002030-200008180-00029","article-title":"Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV\/HIV chimera.","volume":"14","author":"Le Grand","year":"2000","journal-title":"AIDS"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.74.20.9771-9775.2000","article-title":"Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).","volume":"74","author":"Otten","year":"2000","journal-title":"J Virol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.270.5239.1197","article-title":"Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.","volume":"270","author":"Tsai","year":"1995","journal-title":"Science"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/sextrans-2011-050371","article-title":"Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysis.","volume":"88","author":"Chacko","year":"2012","journal-title":"Sex Transm Infect"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/hiv.12797","article-title":"Post-exposure prophylaxis for HIV infection in sexual assault victims.","volume":"21","author":"Inciarte","year":"2020","journal-title":"HIV Med"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.chiabu.2017.04.014","article-title":"Improving HIV post-exposure prophylaxis rates after pediatric acute sexual assault.","volume":"69","author":"Schilling","year":"2017","journal-title":"Child Abuse Negl"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/archdischild-2015-309297","article-title":"Post-exposure prophylaxis guidelines for children and adolescents potentially exposed to HIV.","volume":"102","author":"Bamford","year":"2017","journal-title":"Arch Dis Child"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1503\/cmaj.170494","article-title":"Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.","volume":"189","author":"Tan","year":"2017","journal-title":"CMAJ"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/cid\/ciu118","article-title":"Patient attrition between the emergency department and clinic among individuals presenting for HIV nonoccupational postexposure prophylaxis.","volume":"58","author":"Bogoch","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1097\/QAD.0000000000000505","article-title":"Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis.","volume":"28","author":"Ford","year":"2014","journal-title":"AIDS"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"e0202267","DOI":"10.1371\/journal.pone.0202267","article-title":"A mixed methods study of non-occupational post-exposure prophylaxis at an STI clinic in Singapore: five-year retrospective analysis and providers\u2019 perspectives.","volume":"13","author":"Teo","year":"2018","journal-title":"PLoS One"},{"key":"R31-20250614","first-page":"455","article-title":"A prospective examination of post-traumatic stress disorder in rape victims.","volume":"5","author":"Rothbaum","year":"1992","journal-title":"J Trauma Stress"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1093\/jac\/dkx246","article-title":"Tenofovir disoproxil fumarate\/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis.","volume":"72","author":"Inciarte","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1468-1293.2005.00288.x","article-title":"The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.","volume":"6","author":"Winston","year":"2005","journal-title":"HIV Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:06:24Z","timestamp":1749942384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004370","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}